Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: Bellwether for vascular disease?

Cardiovascular Research

Volumn 75, Issue 4, 2007, Pages 679-689

  Haurani, Mounir J ^a   Pagano, Patrick J ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Adventitia; Autocrine; Fibroblast; Free radicals; Hypertrophy; NADPH Oxidase; Paracrine; Reactive oxygen species; Remodeling

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEIN GP 22 PHOX; GLYCOPROTEIN GP 47 PHOX; HYDROGEN PEROXIDE; PROTEIN NOX1; PROTEIN NOX4; PROTEIN NOXA1; PROTEIN NOXO1; RAC PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ADVENTITIA; ANGIOGENESIS; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; AUTOCRINE EFFECT; BLOOD VESSEL INJURY; CELL FUNCTION; CELL MEMBRANE PERMEABILITY; ENDOTHELIAL DYSFUNCTION; FIBROBLAST; HUMAN; HYPERTENSION; HYPERTROPHY; INFLAMMATION; LIPID OXIDATION; NONHUMAN; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PULMONARY HYPERTENSION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TUNICA MEDIA; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

ANIMALS; ATHEROSCLEROSIS; AUTOCRINE COMMUNICATION; CONNECTIVE TISSUE; CYTOKINES; FIBROBLASTS; HUMANS; MUSCLE, SMOOTH, VASCULAR; NADPH OXIDASE; PARACRINE COMMUNICATION; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 34547791794     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2007.06.016     Document Type: Review

References (136)

1. Chen J.N., Haffter P., Odenthal J., Vogelsang E., Brand M., van Eeden F.J., et al. Mutations affecting the cardiovascular system and other internal organs in zebrafish. Development 123 (1996) 293-302
2. Gassmann M., Fandrey J., Bichet S., Wartenberg M., Marti H.H., Bauer C., et al. Oxygen supply and oxygen-dependent gene expression in differentiating embryonic stem cells. Proc Natl Acad Sci U S A 93 (1996) 2867-2872
3. Weinstein B.M. What guides early embryonic blood vessel formation?. Dev Dyn 215 (1999) 2-11
4. Semenza G.L., Agani F., Iyer N., Kotch L., Laughner E., Leung S., et al. Regulation of cardiovascular development and physiology by hypoxia-inducible factor 1. Ann N Y Acad Sci 874 (1999) 262-268
5. Conway E.M., Collen D., and Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res 49 (2001) 507-521
6. Tomanek R.J. Formation of the coronary vasculature during development. Angiogenesis 8 (2005) 273-284
7. phox-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res 91 (2002) 1160-1167
8. Chen J.X., Zeng H., Lawrence M.L., Blackwell T.S., and Meyrick B. Angiopoietin-1-induced angiogenesis is modulated by endothelial NADPH oxidase. Am J Physiol Heart Circ Physiol 291 (2006) H1563-H1572
9. Hartlapp I., Abe R., Saeed R.W., Peng T., Voelter W., Bucala R., et al. Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J 15 (2001) 2215-2224
10. Cucoranu I., Clempus R., Dikalova A., Phelan P.J., Ariyan S., Dikalov S., et al. NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res 97 (2005) 900-907
11. Pagano P. NAD(P)H oxidase: marker of the dedifferentiated neointimal smooth muscle cell?. Arterioscler Thromb Vasc Biol 21 (2001) 175-177
12. Suh Y.A., Arnold R.S., Lassegue B., Shi J., Xu X., Sorescu D., et al. Cell transformation by the superoxide-generating oxidase Mox1 [letter]. Nature 401 (1999) 79-82
13. Wang H.D., Xu S., Johns D.G., Du Y., Quinn M.T., Cayatte A.J., et al. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ Res 88 (2001) 947-953
14. Liu J., Ormsby A., Oja-Tebbe N., and Pagano P.J. Gene transfer of NAD(P)H oxidase inhibitor to the vascular adventitia attenuates medial smooth muscle hypertrophy. Circ Res 95 (2004) 587-594
15. Bush E., Maeda N., Kuziel W.A., Dawson T.C., Wilcox J.N., DeLeon H., et al. CC chemokine receptor 2 is required for macrophage infiltration and vascular hypertrophy in angiotensin II-induced hypertension. Hypertension 36 (2000) 360-363
16. Janabi M., Yamashita S., Hirano K., Matsumoto K., Nozaki S., and Matsuzawa Y. Reduced secretion of tumor necrosis factor-α and interleukin-1β from monocyte-derived macrophages of CD36-deficient subjects in response to oxidized LDL. In: Kita T., and Yokode M. (Eds). . Lipoprotein Metabolism and Atherogenesis (2000), Springer-Verlag, Tokyo 227-229
17. Liu J., Yang F., Yang X.P., Jankowski M., and Pagano P.J. NAD(P)H oxidase mediates angiotensin II-induced vascular macrophage infiltration and medial hypertrophy. Arterioscler Thromb Vasc Biol 23 (2003) 776-782
18. Scott N.A., Cipolla G.D., Ross C.E., Dunn B., Martin F.H., Simonet L., et al. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 93 (1996) 2178-2187
19. Wilcox J.N., Okamoto E.I., Nakahara K.I., and Vinten-Johansen J. Perivascular responses after angioplasty which may contribute to postangioplasty restenosis: a role for circulating myofibroblast precursors?. Ann N Y Acad Sci 947 (2001) 68-90 [dicussion 90-2.:68-90]
20. Li G., Chen S.J., Oparil S., Chen Y.F., and Thompson J.A. Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries. Circulation 101 (2000) 1362-1365
21. de Leon H., Ollerenshaw J.D., Griendling K.K., and Wilcox J.N. Adventitial cells do not contribute to neointimal mass after balloon angioplasty of the rat common carotid artery. Circulation 104 (2001) 1591-1593
22. Capers IV Q., Alexander R.W., Lou P., de Leon H., Wilcox J.N., Ishizaka N., et al. Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats. Hypertension 30 (1997) 1397-1402
23. Shi Y., Niculescu R., Wang D., Patel S., Davenpeck K.L., and Zalewski A. Increased NAD(P)H oxidase and reactive oxygen species in coronary arteries after balloon injury. Arterioscler Thromb Vasc Biol 21 (2001) 739-745
24. phox in human coronary arteries. Circulation 100 (1999) 1494-1498
25. Allbutt C. Diseases of the Arteries Including Angina Pectoris (1915), Macmillan and Co., London
26. Schwartz C.J., and Mitchell J.R.A. Cellular infiltration of the human arterial adventitia associated with atheromatous plaques. Circulation 26 (1962) 73-78
27. phox contributes to NADPH oxidase activity in aortic fibroblasts but not smooth muscle cells. Am J Physiol Heart Circ Physiol 285 (2003) H2284-H2289
28. Pagano P.J., Ito Y., Tornheim K., Gallop P.M., Tauber A.I., and Cohen R.A. An NADPH oxidase superoxide-generating system in the rabbit aorta. Am J Physiol 268 (1995) H2274-H2280
29. Pagano P.J., Clark J.K., Cifuentes-Pagano M.E., Clark S.M., Callis G.M., and Quinn M.T. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci U S A 94 (1997) 14483-14488
30. Arribas S.M., Gonzalez C., Graham D., Dominiczak A.F., and McGrath J.C. Cellular changes induced by chronic nitric oxide inhibition in intact rat basilar arteries revealed by confocal microscopy. J Hypertens 15 (1997) 1685-1693
31. Barker S.G., Tilling L.C., Miller G.C., Beesley J.E., Fleetwood G., Stavri G.T., et al. The adventitia and atherogenesis: removal initiates intimal proliferation in the rabbit which regresses on generation of a 'neoadventitia'. Atherosclerosis 105 (1994) 131-144
32. Wilcox J.N., Waksman R., King S.B., and Scott N.A. The role of the adventitia in the arterial response to angioplasty: the effect of intravascular radiation. Int J Radiat Oncol Biol Phys 36 (1996) 789-796
33. Shi Y., Pieniek M., Fard A., O'Brien J., Mannion J.D., and Zalewski A. Adventitial remodeling after coronary arterial injury. Circulation 93 (1996) 340-348
34. Kantachuvesiri S., Fleming S., Peters J., Peters B., Brooker G., Lammie A.G., et al. Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular disease. J Biol Chem 276 (2001) 36727-36733
35. Chazova I., Loyd J.E., Zhdanov V.S., Newman J.H., Belenkov Y., and Meyrick B. Pulmonary artery adventitial changes and venous involvement in primary pulmonary hypertension. Am J Pathol 146 (1995) 389-397
36. Belknap J.K., Orton E.C., Ensley B., Tucker A., and Stenmark K.R. Hypoxia increases bromodeoxyuridine labeling indices in bovine neonatal pulmonary arteries. Am J Respir Cell Mol Biol 16 (1997) 366-371
37. Herrmann J., Lerman L.O., Rodriguez-Porcel M., Holmes Jr. D.R., Richardson D.M., Ritman E.L., et al. Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. Cardiovasc Res 51 (2001) 762-766
38. Herrmann J., Samee S., Chade A., Rodriguez P.M., Lerman L.O., and Lerman A. Differential effect of experimental hypertension and hypercholesterolemia on adventitial remodeling. Arterioscler Thromb Vasc Biol 25 (2005) 447-453
39. Griendling K.K., Minieri C.A., Ollerenshaw J.D., and Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74 (1994) 1141-1148
40. Seshiah P.N., Weber D.S., Rocic P., Valppu L., Taniyama Y., and Griendling K.K. Angiotensin II stimulation of NAD(P)H oxidase activity. Upstream mediators. Circ Res 91 (2002) 406-413
41. phox. Role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 23 (2003) 981-987
42. phox in aortas from angiotensin II-infused mice. Am J Physiol Heart Circ Physiol 279 (2000) H2234-H2240
43. Rey F.E., and Pagano P.J. The reactive adventitia. Fibroblast oxidase in vascular function. Arterioscler Thromb Vasc Biol 22 (2002) 1962-1971
44. Wang H.D., Pagano P.J., Du Y., Cayatte A.J., Quinn M.T., Brecher P., et al. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ Res 82 (1998) 810-818
45. Wang H.D., Hope S., Du Y., Quinn M.T., Cayatte A., Pagano P.J., et al. Paracrine role of adventitial superoxide anion in mediating spontaneous tone of the isolated rat aorta in angiotensin II-induced hypertension. Hypertension 33 (1999) 1225-1232
46. phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts. Hypertension 32 (1998) 331-337
47. phox. Beyond the endothelium [editorial]. Circ Res 87 (2000) 1-3
48. Sorescu D., Weiss D., Lassègue B., Clempus R.E., Szöcs K., Sorescu G.P., et al. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105 (2002) 1429-1435
49. Mohazzab-H K.M., Kaminski P.M., and Wolin M.S. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol 266 (1994) H2568-H2572
50. phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 271 (1996) 23317-23321
51. phox may participate in forming this oxidase in vitro and in vivo. J Biol Chem 274 (1999) 19814-19822
52. Touyz R.M., Chen X., Tabet F., Yao G., He G., Quinn M.T., et al. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries. Regulation by angiotensin II. Circ Res 90 (2002) 1205-1213
53. phox homologues in vascular smooth muscle cells. Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88 (2001) 888-894
54. Geiszt M., Kopp J.B., Várnai P., and Leto T.L. Identification of Renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci U S A 97 (2000) 8010-8014
55. Shiose A., Kuroda J., Tsuruya K., Hirai M., Hirakata H., Naito S., et al. A novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem 276 (2001) 1417-1423
56. Jones S.A., O'Donnell V.B., Wood J.D., Broughton J.P., Hughes E.J., and Jones O.T.G. Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol 271 (1996) H1626-H1634
57. Meyer J.W., Holland J.A., Ziegler L.M., Chang M.M., Beebe G., and Schmitt M.E. Identification of a functional leukocyte-type NADPH oxidase in human endothelial cells: a potential atherogenic source of reactive oxygen species. Endothelium 7 (1999) 11-22
58. Ago T., Kitazono T., Ooboshi H., Iyama T., Han Y.H., Takada J., et al. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 109 (2004) 227-233
59. Martyn K.D., Frederick L.M., von Loehneysen K., Dinauer M.C., and Knaus U.G. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal 18 (2006) 69-82
60. 2 and plays an integral role in insulin signal transduction. Mol Cell Biol 24 (2004) 1844-1854
61. Leopold J.A., Upchurch G.R., Welch G.N., and Loscalzo J. Cyclic strain induces nitric oxide synthase in vascular smooth muscle cells. Circulation 94 (1996) I-154
62. Cheng J.J., Wung B.S., Chao Y.J., and Wang D.L. Cyclin strain-induced reactive oxygen species involved in ICAM-1 gene induction in endothelial cells. Hypertension 31 (1998) 125-130
63. Matsushita H., Lee K., and Tsao P.S. Cyclic strain induces reactive oxygen species production via an endothelial NAD(P)H oxidase. J Cell Biochem Suppl 36 (2001) 99-106
64. Leopold J.A., and Loscalzo J. Cyclic strain modulates resistance to oxidant stress by increasing G6PDH expression in smooth muscle cells. Am J Physiol Heart Circ Physiol 279 (2000) H2477-H2485
65. Weintraub N.L. Nox response to injury [editorial]. Arterioscler Thromb Vasc Biol 22 (2002) 4-5
66. Oeckler R.A., Kaminski P.M., and Wolin M.S. Stretch enhances contraction of bovine coronary arteries via an NAD(P)H oxidase-mediated activation of the extracellular signal-regulated kinase mitogen-activated protein kinase cascade. Circ Res 92 (2003) 23-31
67. Souza H.P., Souza L.C., Anastacio V.M., Pereira A.C., Junqueira M.d.L., Krieger J.E., et al. Vascular oxidant stress early after balloon injury: evidence for increased NAD(P)H oxidoreductase activity. Free Radic Biol Med 28 (2000) 1232-1242
68. Griendling K.K., and Ushio-Fukai M. Redox control of vascular smooth muscle proliferation. J Lab Clin Med 132 (1998) 9-15
69. Shi Y., O'Brien Jr. J.E., Fard A., Mannion J.D., Wang D., and Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 94 (1996) 1655-1664
70. Dourron H.M., Jacobson G.M., Park J.L., Liu J., Reddy D.J., Scheel M.L., et al. Perivascular gene transfer of NADPH oxidase inhibitor suppresses angioplasty-induced neointimal proliferation of rat carotid artery. Am J Physiol Heart Circ Physiol 288 (2005) H946-H953
71. Weaver M., Liu J., Pimentel D., Reddy D.J., Harding P., Peterson E.L., et al. Adventitial delivery of dominant-negative p67phox attenuates neointimal hyperplasia of the rat carotid artery. Am J Physiol Heart Circ Physiol 290 (2006) H1933-H1941
72. Warnholtz A., Nickenig G., Schulz E., Macharzina R., Bräsen J.H., Skatchkov M., et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis. Evidence for involvement of the renin-angiotensin system. Circulation 99 (1999) 2027-2033
73. Cathcart M.K. Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages. Contributions to atherosclerosis. Arterioscler Thromb Vasc Biol 24 (2004) 23-28
74. Sorescu D., Szöcs K., and Griendling K.K. NAD(P)H oxidases and their relevance to atherosclerosis. Trends Cardiovasc Med 11 (2001) 124-131
75. phox is required for atherosclerotic lesion progression in ApoE-/- mice. J Clin Invest 108 (2001) 1513-1522
76. Krick S., Hanze J., Eul B., Savai R., Seay U., Grimminger F., et al. Hypoxia-driven proliferation of human pulmonary artery fibroblasts: cross-talk between HIF-1alpha and an autocrine angiotensin system. FASEB J 19 (2005) 857-859
77. Morrell N.W., Morris K.G., and Stenmark K.R. Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension. Am J Physiol 269 (1995) H1186-H1194
78. phox). Am J Physiol Lung Cell Mol Physiol 290 (2006) L2-L10
79. Kuwahara F., Kai H., Tokuda K., Shibata R., Kusaba K., Tahara N., et al. Hypoxia-inducible factor-1alpha/vascular endothelial growth factor pathway for adventitial vasa vasorum formation in hypertensive rat aorta. Hypertension 39 (2002) 46-50
80. Lee D.L., Sturgis L.C., Labazi H., Osborne Jr. J.B., Fleming C., Pollock J.S., et al. Angiotensin II hypertension is attenuated in interleukin-6 knockout mice. Am J Physiol Heart Circ Physiol 290 (2006) H940
81. Wassmann S., Stumpf M., Strehlow K., Schmid A., Schieffer B., Böhm M., et al. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ Res 94 (2004) 534-541
82. Yamagishi S.I., Inagaki Y., Nakamura K., Abe R., Shimizu T., Yoshimura A., et al. Pigment epithelium-derived factor inhibits TNF-α-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation. J Mol Cell Cardiol 37 (2004) 497-506
83. 2-generating NADH oxidase in human lung fibroblasts by transforming growth factor β1. J Biol Chem 270 (1995) 30334-30338
84. Meier B., Radeke H.H., Selle S., Younes M., Sies H., Resch K., et al. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-α. Biochem J 263 (1989) 539-545
85. Fujiwara M., Muragaki Y., and Ooshima A. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity. Arch Dermatol Res 297 (2005) 161-169
86. Han Y., Runge M.S., and Brasier A.R. Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-κB transcription factors. Circ Res 84 (1999) 695-703
87. Lee A.A., Dillmann W.H., McCulloch A.D., and Villarreal F.J. Angiotensin II stimulates the autocrine production of transforming growth factor-β1 in adult rat cardiac fibroblasts. J Mol Cell Cardiol 27 (1995) 2347-2357
88. Loppnow H., and Libby P. Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. J Clin Invest 85 (1990) 731-738
89. Sjölund M., Hedin U., Sejersen T., Heldin C.H., and Thyberg J. Arterial smooth muscle cells express platelet-derived growth factor (PDGF) A chain mRNA, secrete a PDGF-like mitogen, and bind exogenous PDGF in a phenotype- and growth state-dependent manner. J Cell Biol 106 (1988) 403-413
90. Schieffer B., Luchtefeld M., Braun S., Hilfiker A., Hilfiker-Kleiner D., and Drexler H. Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction. Circ Res 87 (2000) 1195-1201
91. Shen W.L., Gao P.J., Che Z.Q., Ji K.D., Yin M., Yan C., et al. NAD(P)H oxidase-derived reactive oxygen species regulate angiotensin-II induced adventitial fibroblast phenotypic differentiation. Biochem Biophys Res Commun 339 (2006) 337-343
92. Chalothorn D., Zhang H., Clayton J.A., Thomas S.A., and Faber J.E. Catecholamines augment collateral vessel growth and angiogenesis in hindlimb ischemia. Am J Physiol Heart Circ Physiol 289 (2005) H947-H959
93. Jacobson G.M., Dourron H.M., Liu J., Carretero O.A., Reddy D.J., Andrzejewski T., et al. Novel NAD(P)H oxidase inhibitor suppresses angioplasty-induced superoxide and neointimal hyperplasia of rat carotid artery. Circ Res 92 (2003) 637-643
94. Cai H. NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease. Circ Res 96 (2005) 818-822
95. 2-induced O2 production by a non-phagocytic NAD(P)H oxidase causes oxidant injury. J Biol Chem 276 (2001) 29251-29256
96. Griendling K.K., Sorescu D., Lassègue B., and Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 20 (2000) 2175-2183
97. Griendling K.K., and Harrison D.G. Dual role of reactive oxygen species in vascular growth. Circ Res 85 (1999) 562-563
98. Zimmerman M.C., Lazartigues E., Lang J.A., Sinnayah P., Ahmad I.M., Spitz D.R., et al. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 91 (2002) 1038-1945
99. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 271 (1996) C1424-C1437
100. Lancaster Jr. J.R. A tutorial on the diffusibility and reactivity of free nitric oxide. Nitric Oxide 1 (1997) 18-30
101. Mao G.D., Thomas P.D., Lopaschuk G.D., and Poznansky M.J. Superoxide dismutase (SOD)-catalase conjugates. Role of hydrogen peroxide and the Fenton reaction in SOD toxicity. J Biol Chem 268 (1993) 416-420
102. Ruef J., Rao G.N., Li F., Bode C., Patterson C., Bhatnagar A., et al. Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxy-2-nonenal. Circulation 97 (1998) 1071-1078
103. Ardanaz N., and Pagano P.J. Hydrogen peroxide as a paracrine vascular mediator: regulation and signaling leading to dysfunction. Exp Biol Med (Maywood) 231 (2006) 237-251
104. Shi-Wen X., Chen Y., Denton C.P., Eastwood M., Renzoni E.A., Bou-Gharios G., et al. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol Biol Cell 15 (2004) 2707-2719
105. Wedgwood S., and Black S.M. Endothelin-1 decreases endothelial NOS expression and activity through ETA receptor-mediated generation of hydrogen peroxide. Am J Physiol Lung Cell Mol Physiol 288 (2005) L480-L487
106. Guikema B.J., Ginnan R., Singer H.A., and Jourd'heuil D. Catalase potentiates interleukin-1beta-induced expression of nitric oxide synthase in rat vascular smooth muscle cells. Free Radic Biol Med 38 (2005) 597-605
107. Jaimes E.A., Sweeney C., and Raij L. Effects of the reactive oxygen species hydrogen peroxide and hypochlorite on endothelial nitric oxide production. Hypertension 38 (2001) 877-883
108. Cai H., Li Z., Dikalov S., Holland S.M., Hwang J., Jo H., et al. NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin II. J Biol Chem 277 (2002) 48311-48317
109. phox in mice. Am J Physiol Heart Circ Physiol 288 (2005) H7-H12
110. Weiss N., Zhang Y.Y., Heydrick S., Bierl C., and Loscalzo J. Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction. Proc Natl Acad Sci U S A 98 (2001) 12503-12508
111. - levels in rabbit carotid artery. Am J Physiol 277 (1999) H2109-H2114
112. Bouloumié A., Bauersachs J., Linz W., Schölkens B.A., Wiemer G., Fleming I., et al. Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. Hypertension 30 (1997) 934-941
113. Li W.G., Stoll L.L., Rice J.B., Xu S.P., Miller Jr. F.J., Chatterjee P., et al. Activation of NAD(P)H oxidase by lipid hydroperoxides: mechanism of oxidant-mediated smooth muscle cytotoxicity. Free Radic Biol Med 34 (2003) 937-946
114. 2 in angiotensin II-induced vascular hypertrophy. Hypertension 32 (1998) 488-495
115. Yoshizumi M., Abe J., Haendeler J., Huang Q., and Berk B.C. Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species. J Biol Chem 275 (2000) 11706-11712
116. Abe J., Kusuhara M., Ulevitch R.J., Berk B.C., and Lee J.D. Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase. J Biol Chem 271 (1996) 16586-16590
117. Ushio-Fukai M., Alexander R.W., Akers M., and Griendling K.K. p38 mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem 273 (1998) 15022-15029
118. Ushio-Fukai M., Alexander R.W., Akers M., Yin Q., Fujio Y., Walsh K., et al. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem 274 (1999) 22699-22704
119. 2. Hypertension 46 (2005) 732-737
120. phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 80 (1997) 45-51
121. Egashira K. Molecular mechanisms mediating inflammation in vascular disease. Special reference to monocyte chemoattractant protein-1. Hypertension 41 (2003) 834-841
122. Mazurek T., Zhang L., Zalewski A., Mannion J.D., Diehl J.T., Arafat H., et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108 (2003) 2460-2466
123. Ni W., Kitamoto S., Ishibashi M., Usui M., Inoue S., Hiasa K., et al. Monocyte chemoattractant protein-1 is an essential inflammatory mediator in Angiotensin II-induced progression of established atherosclerosis in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol 24 (2004) 534-539
124. Lee P.C., Ho I.C., and Lee T.C. Oxidative stress mediates sodium arsenite-induced expression of heme oxygenase-1, monocyte chemoattractant protein-1, and interleukin-6 in vascular smooth muscle cells. Toxicol Sci 85 (2005) 541-550
125. Sano M., Fukuda K., Kodama H., Pan J., Saito M., Matsuzaki J., et al. Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem 275 (2000) 29717-29723
126. Egashira K., Koyanagi M., Kitamoto S., Ni W., Kataoka C., Morishita R., et al. Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis. FASEB J 14 (2000) 1974-1978
127. Selzman C.H., Miller S.A., Zimmerman M.A., Gamboni-Robertson F., Harken A.H., and Banerjee A. Monocyte chemotactic protein-1 directly induces human vascular smooth muscle proliferation. Am J Physiol Heart Circ Physiol 283 (2002) H1455-H1461
128. Parenti A., Bellik L., Brogelli L., Filippi S., and Ledda F. Endogenous VEGF-A is responsible for mitogenic effects of MCP-1 on vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 286 (2004) H1978-H1984
129. Ikeda U., Okada K., Ishikawa S.E., Saito T., Kasahara T., and Shimada K. Monocyte chemoattractant protein 1 inhibits growth of rat vascular smooth muscle cells. Am J Physiol 268 (1995) H1021-H1026
130. Viedt C., Vogel J., Athanasiou T., Shen W., Orth S.R., Kübler W., et al. Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-κB and activator protein-1. Arterioscler Thromb Vasc Biol 22 (2002) 914-920
131. Liao D.F., Monia B., Dean N., and Berk B.C. Protein kinase C-zeta mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells. J Biol Chem 272 (1997) 6146-6150
132. Touyz R.M., Yao G., Viel E., Amiri F., and Schiffrin E.L. Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells. J Hipertens 22 (2004) 1141-1149
133. Cheng Z.J., Vapaatalo H., and Mervaala E. Angiotensin II and vascular inflammation. Med Sci Monit 11 (2005) RA194-RA205
134. Golovchenko I., Goalstone M.L., Watson P., Brownlee M., and Draznin B. Hyperinsulinemia enhances transcriptional activity of nuclear factor-κB Induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells. Circ Res 87 (2000) 746-752
135. Kranzhöfer R., Schmidt J., Pfeiffer C.A.H., Hagl S., Libby P., and Kübler W. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19 (1999) 1623-1629
136. Ruiz-Ortega M., Lorenzo O., Ruperez M., Suzuki Y., and Egido J. Angiotensin II activates nuclear transcription factor-kappaB in aorta of normal rats and in vascular smooth muscle cells of AT1 knockout mice. Nephrol Dial Transplant 16 Suppl 1 (2001) 27-33